SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
CardioComm Solutions, Inc. (EKGGF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 19/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EKGGF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.50
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.01 |
$1.73M |
$-599.75K |
-34.8% |
| 2016 |
$0.00 |
$1.56M |
$-23.06K |
-1.5% |
| 2017 |
$0.00 |
$1.74M |
$39.61K |
2.3% |
| 2018 |
$0.00 |
$1.08M |
$-577.06K |
-53.7% |
| 2019 |
$-0.01 |
$874.89K |
$-1.06M |
-121.4% |
| 2020 |
$0.00 |
$834.79K |
$-63.61K |
-7.6% |
| 2021 |
$0.00 |
$682.51K |
$283.00 |
0% |
| 2022 |
$0.00 |
$995.81K |
$-2.46K |
-0.2% |
| 2023 |
$0.00 |
$876.41K |
$-97.33K |
-11.1% |
| 2024 |
$0.00 |
$526.68K |
$-194.58K |
-36.9% |
